The Operating System for
Pharma 5.0
I'm A.B. Modi, founder of Ligant.ai. We are building the human and machine collaboration layer for cell and gene therapy biotech. One platform where R&D, regulatory, and quality teams move at the speed, accuracy, and confidence that modern drug discovery demands.
Why Drug Discovery Is Slower Than It Should Be
The science is ready. The regulations exist for good reason. What is missing is the connective tissue: a place where every stakeholder inside a biotech can collaborate on the same evidence, with the same rigor, and at the same machine assisted speed. That is the gap Ligant.ai is built to close.
Pharma 4.0 digitized the lab. Pharma 5.0 changes who does the work.
Cell and gene therapy is advancing faster than the tools supporting it. Founders and scientists still stitch together evidence across 20+ databases, write submissions from scratch, and lose months to work that machines can do honestly, with citations and audit trails, in a fraction of the time.
Ligant.ai keeps the scientist as the decision-maker and gives them an agentic team that handles the data-intensive synthesis. Every claim is cited. Every decision is logged. Nothing is hidden behind a black box.
- ✓ Scientists decide. Agents do the evidence work.
- ✓ Claim-level citations, append-only audit trails.
- ✓ One system for R&D, regulatory, and quality work.
From hypothesis to investor grade target dossier, without sacrificing rigor.
What Ligant.ai Is Building
We are starting where the pain is sharpest for cell and gene therapy founders, then expanding into the full operating layer biotech teams need to run with confidence.
R&D: CAR-T Target Assessment
An agentic head of target assessment for pre seed and pre Series A founders. Consulting grade CAR-T evaluation across biological, strategic, and economic viability, delivered in weeks rather than months.
- ✓ Three-Gate Framework
- ✓ 20+ Database Synthesis
- ✓ Claim-Level Citations
Regulatory Affairs
Agentic workflows that track global regulatory changes, draft IND and NDA technical writing, and assemble submission ready dossiers, with every section traceable to source.
- ✓ Global Reg-Change Tracking
- ✓ Submission Doc Automation
- ✓ Source-Traceable Sections
Quality Operations
QMS orchestration built for cell and gene therapy realities: deviation management, CAPA cycles, and continuous audit readiness, wired into the same evidence layer your R&D team uses.
- ✓ QMS Orchestration
- ✓ Deviation & CAPA Automation
- ✓ Continuous Audit Readiness
Why I'm Building This
Over fifteen years building businesses, building software, and shipping product for hundreds of companies. Five years embedded inside pharma and biotech. The gap kept showing up in the same places, so I decided to build the platform that closes it.
15+ Years Building Software, Building Businesses
From bootstrapped startups to enterprise workflows, I have architected and shipped software for hundreds of companies, translating messy business problems into systems that operators actually use.
5 Years Inside Pharma & Biotech
Embedded with QA, RA, and HEOR teams across pharma and biotech for over five years, with a deep focus on cell and gene therapy companies. The pattern repeats across every program: rigorous science, full respect for the regs, and no shared system that lets cross functional teams move at the speed and accuracy the industry now demands.
Computational Power Is the New Bench
The compute is here. The models are here. What is missing is a faithful, auditable, scientist led system that puts all of it to work on the hardest parts of drug discovery, starting with cell and gene therapy, where the science is moving fastest.
How Ligant.ai Works
A scientist-led loop where agents do the synthesis, humans make the calls, and every decision leaves a trail.
Frame the Question
Scientists define the target, hypothesis, or decision they need to make. The platform translates intent into an evidence plan.
Agentic Synthesis
Specialist agents query 20+ biomedical databases, reconcile sources, and assemble evidence with every claim cited at the line level.
Human Decision Gates
Critique agents stress-test the conclusions. Scientists review, push back, and make the call. The platform halts when evidence is insufficient.
Audit-Ready Output
Dossiers, target assessments, and submission grade artifacts, each backed by an append only audit trail behind every word.
Let's Build Pharma 5.0 Together
If you are a cell or gene therapy founder, scientist, or operator, or you want to work with us on Ligant.ai, I would love to hear from you.